Skip Navigation

COVID-19 Update

We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Please know that our vaccine supply is extremely small. Read all COVID-19 Vaccine Information.

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts


Discovery: Gary Schauder

Discovery: Gary Schauder

Gary Schauder, who faced bullets and Agent Orange while serving his country in Vietnam, was not about to let prostate cancer scare him. When Schauder’s prostate cancer returned a few years after surgery and continued to grow on treatments aimed at slowing its progress, his wife encouraged him to make an appointment at the Johns Hopkins Kimmel Cancer Center. Under the care of prostate cancer expert Mario Eisenberger and nurse practitioner Vicki Sinibaldi (pictured at left), he began treatment with pharmacological testosterone — an experimental approach developed by prostate cancer researcher Sam Denmeade. “I received the drug for the first time about two years ago,” says Schauder. “My PSA went from 14 to undetectable. It’s starting to elevate a little now, but not much. It’s not even up to one.” The 72-year-old says he feels energetic and lifts weights for over an hour every day. “It’s nice to know I’m coming to a place where I feel like they’re helping me and using what they learn from me to help others,” says Schauder. “One day, the research they’re doing here is going to wipe out this disease.”

back to top button